IShares Biotechnology ETF Forward View - Simple Moving Average

IBB ETF  USD 167.87  -1.15  -0.68%   
The Simple Moving Average output for iShares Biotechnology ETF is derived from daily price data across the evaluation window. The error pattern reveals whether the model tracked prices consistently or diverged during volatile sessions. Parameters are re-estimated as new trading sessions are recorded, keeping the forecast current. The Simple Moving Average model projects IShares Biotechnology at 168.44 for the next trading day, above the most recent closing price. IShares Biotechnology's Simple Moving Average forecast is intended for short-term analytical reference.
The two-period moving average forecast for IShares Biotechnology replaces each daily closing price with the mean of that price and the preceding day's close. This produces a lightly smoothed series that closely tracks the actual price with a one-period lag.

Simple Moving Average Price Forecast For the 29th of April

Over a 90-day horizon, the Simple Moving Average model forecasts IShares Biotechnology at 168.44 for the next trading day, with a mean absolute deviation of 2.03 , mean absolute percentage error of 0.01 , and sum of absolute errors of 119.84 .
This represents a very tight forecast — the model closely tracks IShares Biotechnology's recent price behavior. This output is intended for short-term analytical reference.

ETF Forecast Pattern

Backtest IShares Biotechnology  IShares Biotechnology Price Prediction  Research Analysis  

Forecasted Value

The projected range for IShares Biotechnology reflects the model's ability to define credible downside and upside scenarios for the next trading day. The current forecast range spans downside near 167.05 and upside near 169.83. The narrow range indicates limited short-term dispersion.
Market Value
167.87
167.05
168.44
Expected Value
169.83

Model Predictive Factors

The table below summarizes the Simple Moving Average model's error metrics for IShares Biotechnology ETF. Lower MAD and MAPE values indicate tighter forecast accuracy. AIC measures relative model quality — lower values indicate less information loss and a better-fitting model. A large Bias suggests systematic over- or under-prediction.
AICAkaike Information Criteria116.3093
BiasArithmetic mean of the errors 0.1319
MADMean absolute deviation2.0313
MAPEMean absolute percentage error0.012
SAESum of the absolute errors119.845
With only two periods, the model is highly responsive to recent iShares Biotechnology ETF price changes but provides minimal noise reduction. It is best suited for short-term evaluation of low-to-moderate volatility price series. A widening gap between the forecast and actual values may indicate an acceleration in price momentum.

Other Forecasting Options for IShares Biotechnology

Relative Strength Index values for IShares measure the speed and magnitude of recent price changes. Recognizing these clusters in IShares Biotechnology's returns informs position size and stop-loss calibration. Candlestick pattern analysis of IShares ETF daily data reveals short-term reversal or continuation signals.

IShares Biotechnology Related Equities

The peer firms below within the Health space frame IShares Biotechnology's pricing and running costs in context. Looking at IShares Biotechnology's pricing multiples next to these peers shows if the stock trades at a premium or discount. Falling behind peers on key ratios may signal headwinds or execution issues worth looking into.
 Risk & Return  Correlation

IShares Biotechnology Market Strength Events

Accumulation/Distribution and Balance of Power for IShares Biotechnology reveal whether buying or selling pressure dominates recent sessions. Balance of Power trending positive indicates that buyers are consistently closing IShares Biotechnology near session highs. These signals help explain whether price direction and session structure are moving together for IShares Biotechnology.

IShares Biotechnology Risk Indicators

Risk indicator analysis for IShares Biotechnology quantifies how much price variability the ETF has exhibited over the measurement window. Downside variance exceeding total variance indicates that negative moves in IShares Biotechnology have been larger or more frequent than positive ones. Mean deviation provides a more intuitive measure of typical price fluctuation than variance because it stays in the same units as IShares Biotechnology's price.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.